HOME >> BIOLOGY >> NEWS
'Mimics' may open screen(ing) door to GPCR drugs

ROCKVILLE, Md.- For starters, a team of scientists at the University of Maryland Biotechnology Institute and partners have engineered "soluble mimics" of rhodopsin, the light-sensing protein that lies deeply embedded in membranes of retina cells of the eye. Next, these mimics may open the door for drug designers to use x-rays, nuclear magnetic resonance (NMR), and other high-resolution structural tools to study the detailed workings of rhodopsin and other members of the superfamily of membrane proteins called G-protein coupled receptors (GPCRs).

In the journal Biochemistry, Kevin D. Ridge and co-authors describe a new approach for structurally characterizing functional regions of the rhodopsin protein that reside outside of the membrane. Assembly of these regions mimics how the receptor interacts with binding molecules called G-proteins. Ridge is a research chemist with UMBI's Center for Advanced Research in Biotechnology (CARB) and the National Institute of Standards and Technology (NIST).

GPCRs are very important to human health because they transmit and transform chemical signals from outside of cell to G-proteins inside the cell that mediate vision, smell, hearing, taste, and other processes. The GPCRs are already the targets of many therapeutic drugs for allergy, pain, hypertension, and other medical conditions.

GPCRs have been notoriously difficult to study at the structural level. They cross through the cell membrane seven times and any fault or mutation in the serpentine-like receptors may lead to a disease or illness. Ridge says engineering soluble mimics of these receptors may help medical researchers discover new drugs that target some of the consequences of these mutations.

Specifically, designing and characterizing "soluble mimics" of GPCRs could benefit structural approaches that are aimed at discovering more rationally designed drugs, possibly with fewer side effects, that could "block a mal
'"/>

Contact: Steve Berberich
berberic@umbi.umd.edu
301-990-4804
University of Maryland Biotechnology Institute
24-Jun-2003


Page: 1 2

Related biology news :

1. Tiny molecules have big potential as cancer drugs, Stanford researcher believes
2. New and better drugs for tuberculosis goal of UH professor
3. New technique helps scientists reveal interactions between genes and drugs
4. New database to help develop AIDS drugs
5. Orange, tangerine peels could be better than drugs for lowering cholesterol
6. New papillomavirus target could lead to specific antiviral drugs for precancerous cervical lesions
7. Newer drugs more effective at curing strep throat than penicillin
8. New software developed at Rensselaer predicts promising ingredients for new drugs
9. Protein abundant in human tumors confers resistance to anticancer drugs
10. Findings could aid efforts to harness nature for making drugs
11. New way to lock DNA-slicing enzyme onto chromosomes could lead to novel anti-cancer drugs

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/30/2017)... 2017 Today, American Trucking Associations announced ... face and eye tracking software, became the newest ... "Artificial intelligence and advanced sensing ... a driver,s attentiveness levels while on the road.  ... detect fatigue and prevent potential accidents, which could ...
(Date:5/23/2017)... -- Hunova, the first robotic gym for the rehabilitation and functional motor sense ... Genoa, Italy . The first 30 robots will be available ... USA . The technology was developed and patented at the IIT ... Movendo Technology thanks to a 10 million euro investment from entrepreneur Sergio ... ...
(Date:5/6/2017)... 5, 2017 RAM Group , ... new breakthrough in biometric authentication based on a ... properties to perform biometric authentication. These new sensors are ... created by Ram Group and its partners. This sensor ... supply chains and security. Ram Group is a ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... BOSTON (PRWEB) , ... October 12, 2017 , ... ... name for two-dimensional representations of a complex biological network, a depiction of a ... a big mess,” said Dmitry Korkin, PhD, associate professor of computer science at ...
(Date:10/12/2017)... ... 12, 2017 , ... AMRI, a global contract research, development ... patient outcomes and quality of life, will now be offering its impurity solutions ... new regulatory requirements for all new drug products, including the finalization of ICH ...
(Date:10/11/2017)... ... 2017 , ... ComplianceOnline’s Medical Device Summit is back for its 4th year. ... San Francisco, CA. The Summit brings together current and former FDA office bearers, regulators, ... government officials from around the world to address key issues in device compliance, quality ...
(Date:10/11/2017)... ... October 11, 2017 , ... A new ... rates in frozen and fresh in vitro fertilization (IVF) transfer cycles. ... to IVF success. , After comparing the results from the fresh and frozen ...
Breaking Biology Technology:
Cached News: